Association of Anti–Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti–Topoisomerase I–Positive Systemic Sclerosis

OBJECTIVE: Anti–topoisomerase I (anti–topo I) autoantibodies in systemic sclerosis (SSc) are associated with diffuse skin involvement and interstitial lung fibrosis. Thus far, however, the relationship between anti–topo I antibody response and disease course has not yet been fully evaluated. This st...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Arthritis Rheumatol
Auteurs principaux: Boonstra, Maaike, Bakker, Jaap A., Grummels, Annette, Ninaber, Maarten K., Ajmone Marsan, Nina, Wortel, Corrie M., Huizinga, Tom W. J., Jordan, Suzana, Hoffman‐Vold, Anna‐Maria, Distler, Oliver, Toes, René E. M., Scherer, Hans Ulrich, de Vries‐Bouwstra, Jeska K.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Systemic Sclerosis
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7702063/
https://ncbi.nlm.nih.gov/pubmed/32840062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41403
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires